Skip to main content

Table 3 Vaccination coverage among surveyed children between baseline and end-line in intervention and control groups a

From: Effectiveness of a smartphone app on improving immunization of children in rural Sichuan Province, China: a cluster randomized controlled trial

 

Intervention group

Control group

Total

Baseline (n = 105), % (95 % CI)

End-line (n = 101), % (95 % CI)

P value

Baseline (n = 109), % (95 % CI)

End-line (n = 104), % (95 % CI)

P value

Baseline (n = 214), % (95 % CI)

End-line (n = 205), % (95 % CI)

P value

BCG

97.3(92.2-99.1)

100.0(96.3-100.0)

0.247*

97.1(91.9-99.0)

99.0(94.8-99.8)

0.622*

97.2(94.0-98.7)

99.5(97.3-99.9)

0.122*

HBV1

99.1(95.0-99.8)

100.0(96.3-100.0)

0.122*

96.2(90.6-98.5)

100(96.5-100)

1.000*

97.7(94.6-99.0)

100(98.2-100)

0.061*

HBV2

95.4(89.7-98.0)

98.0(93.1-99.5)

0.171*

93.3(86.9-96.7)

97.1(91.9-99.0)

0.722*

94.4(90.5-96.8)

97.6(94.4-99.0)

0.100

HBV3

84.4(76.4-90.0)

92.1(85.1-95.9)

0.031

81.9(73.5-88.1)

94.2(88.1-97.4)

0.021

83.2(77.6-87.6)

93.2(88.9-95.9)

0.002

OPV1

97.3(92.2-99.1)

100.0(96.3-100.0)

0.163

98.1(93.3-99.5)

98.1(93.3-99.5)

0.689

97.7(94.6-99.0)

99.0(96.5-99.7)

0.277

OPV2

92.7(86.2-96.2)

97.0(91.6-99.0)

0.138

92.4(85.7-96.1)

96.2(90.6-98.5)

0.269

92.5(88.2-95.3)

96.6(93.1-98.3)

0.450

OPV3

85.3(77.5-90.8)

96.0(90.3-98.5)

0.028

87.6(80.0-92.6)

90.4(83.4-94.8)

0.259

86.5(81.2-90.4)

93.2(88.9-95.9)

0.023

DPT1

98.2(93.6-99.5)

98.0(93.1-99.5)

0.06

92.4(85.7-96.1)

95.2(89.3-98.0)

0.224

95.3(91.6-97.4)

96.6(93.1-98.3)

0.514*

DPT2

88.1(80.7-92.9)

95.1(88.9-97.9)

0.091

88.6(81.1-93.3)

92.3(85.7-96.1)

0.300

88.3(83.3-92.0)

93.7(89.5-96.3)

0.057

DPT3

83.5(75.4-89.3)

90.1(82.7-94.5)

0.181

83.8(75.6-89.6)

89.4(82.2-94.1)

0.207

83.6(78.1-88.0)

89.8(84.9-93.2)

0.066

MV

84.4(76.4-90.0)

96.0(90.3-98.5)

0.001

81.0(72.4-87.3)

90.4(83.4-94.8)

0.190

82.7(77.1-87.2)

93.2(88.9-95.9)

0.001

Five-vaccine immunization**

67.0(57.7-75.1)

84.2(75.8-90.0)

0.028

71.4(62.2-79.2)

81.7(73.5-88.1)

0.014

69.2(62.7-75.0)

82.9(77.2-87.5)

0.001

  1. BCG Bacillus Chalmette Guerin vaccine, HBV1,HBV2, HBV3 1 or 2 or 3 doses of Hepatitis B vaccine, DPT1 DPT2 DPT3 1 or 2 or 3 doses of Pertussis Tetanus Combined vaccine, OPV1 OPV2 OPV3 1 or 2 or 3 doses of Oral Poliomyelitis Vaccine, MV Measles Vaccine
  2. a Chi-square tests were used to compare immunization coverage between baseline and end-line survey unless otherwise specified
  3. *Fisher exact tests were used to compare immunization coverage between baseline and end-line survey
  4. **Five-vaccine immunization indicates1 dose of BCG and measles, and 3 doses of HBV, DPT, OPV
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us